长三角医药上市公司创新效率研究——基于DEA-Malmquist指数分析方法  

Analysis of innovation efficiency of the pharmaceutical companies in Yangtze River Delta based on DEA-Malmquist index model

作　　者：张子砚[1] 曹阳[1] 

机构地区：[1]中国药科大学国际医药商学院,南京211198

出　　处：《上海医药》2014年第9期41-44,共4页Shanghai Medical & Pharmaceutical Journal

摘　　要：本文根据上海证券交易所和深圳证券交易所公布的27家医药上市公司的相关数据,建立了创新投入与产出的评价指标体系,利用DEA-Malmquist指数模型从动态角度分析了2008-2012年度长三角医药上市公司的创新现状以及创新效率的变动趋势。得出影响全要素生产率的主要因素是技术进步指数的结论。Based on the data on 27 pharmaceutical companies from Yangtze River Delta announced by Shanghai Stock Exchange and Shenzhen Stock Exchange, the evaluation index system of innovation inputs and outputs were established to analyze the character and the trends of the innovation efifciency from 2008 to 2012 by using the DEA method Malmquist exponential model. Results showed that technical progress index was the main factor of total factor productivity.

关 键 词：长三角 医药上市公司 DEA-MALMQUIST 创新效率 

分 类 号：F426.72[经济管理—产业经济] F273.1